Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 1;10(4):847-853.
doi: 10.14336/AD.2018.0814. eCollection 2019 Aug.

The Metabolic Activity of Caudate and Prefrontal Cortex Negatively Correlates with the Severity of Idiopathic Parkinson's Disease

Affiliations

The Metabolic Activity of Caudate and Prefrontal Cortex Negatively Correlates with the Severity of Idiopathic Parkinson's Disease

Jun-Sheng Chu et al. Aging Dis. .

Abstract

Positron emission tomography (PET) scan with tracer [18F]-fluorodeoxy-glucose (18F-FDG) is widely used to measure the glucose metabolism in neurodegenerative disease such as Idiopathic Parkinson's disease (IPD). Previous studies using 18F-FDG PET mainly focused on the motor or non-motor symptoms but not the severity of IPD. In this study, we aimed to determine the metabolic patterns of 18F-FDG in different stages of IPD defined by Hoehn and Yahr rating scale (H-Y rating scale) and to identify regions in the brain that play critical roles in disease progression. Fifty IPD patients were included in this study. They were 29 men and 21 women (mean±SD, age 57.7±11.1 years, disease duration 4.0±3.8 years, H-Y 2.2±1.1). Twenty healthy individuals were included as normal controls. Following 18F-FDG PET scan, image analysis was performed using Statistical Parametric Mapping (SPM) and Resting-State fMRI Data Analysis Toolkit (REST). The metabolic feature of IPD and regions-of-interests (ROIs) were determined. Correlation analysis between ROIs and H-Y stage was performed. SPM analysis demonstrated a significant hypometabolic activity in bilateral putamen, caudate and anterior cingulate as well as left parietal lobe, prefrontal cortex in IPD patients. In contrast, hypermetabolism was observed in the cerebellum and vermis. There was a negative correlation (p=0.007, r=-0.412) between H-Y stage and caudate metabolic activity. Moreover, the prefrontal area also showed a negative correlation with H-Y (P=0.033, r=-0.334). Thus, the uptake of FDG in caudate and prefrontal cortex can potentially be used as a surrogate marker to evaluate the severity of IPD.

Keywords: 18F-FDG PET; Parkinson's disease; Statistical Parametric Mapping; metabolic activity.

PubMed Disclaimer

Figures

Fig 1.
Fig 1.
The metabolism of FDG in IPD patients compared to healthy controls. Brain areas with increased/decreased glucose metabolism are superimposed on the Montreal Neurological Institute template (Top row) (p < 0.001, uncorrected) and the 3D render (Bottom row). A) Significant hypometabolism in bilateral putamen, caudate, anterior cingulate, parietal lobe and prefrontal cortex was identified. B) The relative hypermetabolism was identified in the cerebellum and vermis.
Figure 2.
Figure 2.. The relationship between the metabolic activity of ROIs and H-Y stages
A) In caudate, the metabolic activity decreased as H-Y stages increased (p=0.004 r=-0.441). B) Similar to caudate, prefrontal metabolic activity also decreased as H-Y stages increased (p=0.004 r=-0.441). C, D, E and F, show no correlation in vermis (C), angular (D), occipital (E) and temporal lobes (F). The Pearson correlation analysis was performed using SPSS software.

References

    1. Jankovic J (2008). Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry, 79: 368-376. - PubMed
    1. Ma SY, Roytta M, Rinne JO, Collan Y, Rinne UK (1995). Single section and disector counts in evaluating neuronal loss from the substantia nigra in patients with Parkinson's disease. Neuropathol Appl Neurobiol, 21: 341-343. - PubMed
    1. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973). Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci, 20: 415-455. - PubMed
    1. Delval A, Tard C, Defebvre L (2014). Why we should study gait initiation in Parkinson's disease. Neurophysiol Clin, 44: 69-76. - PubMed
    1. Poston KL, Eidelberg D (2010). FDG PET in the Evaluation of Parkinson's Disease. PET Clin, 5: 55-64. - PMC - PubMed

LinkOut - more resources